What Has Been the Progress and Growth of the Gastrointestinal Pathogen Testing Market in Recent Years?
The gastrointestinal pathogen testing market has seen considerable growth due to a variety of factors.
• The gastrointestinal pathogen testing market has grown steadily in recent years. It will grow from $4.05 billion in 2024 to $4.24 billion in 2025, at a compound annual growth rate (CAGR) of 4.6%.
The growth is driven by the higher prevalence of gastrointestinal infections, increased awareness about foodborne illnesses, globalization leading to more travel-related infections, regulatory initiatives for food safety, rising healthcare expenditures, and growing demand for rapid diagnostic solutions.
What Can Be Expected from the Gastrointestinal Pathogen Testing Market Size?
The gastrointestinal pathogen testing market is expected to maintain its strong growth trajectory in upcoming years.
• The gastrointestinal pathogen testing market is projected to grow to $5.01 billion by 2029, with a CAGR of 4.3%.
The growth will be driven by the increasing prevalence of gastrointestinal infections, rising awareness of early detection, expanding healthcare infrastructure in emerging markets, and greater focus on food safety. Key trends will include rapid testing methods, the adoption of molecular diagnostic techniques, expansion of point-of-care testing, automation and robotics for testing processes, novel biomarkers for pathogen detection, and AI/ML integration.
What Are the Critical Driver Fuelling The Gastrointestinal Pathogen Testing Market's Growth?
The rise in foodborne diseases is expected to boost the gastrointestinal pathogen testing market. Foodborne diseases, caused by contaminated food or beverages, are increasing due to changes in food production and safety measures, as well as climate change. Testing helps identify pathogens responsible for illnesses, aiding in treatment and prevention. For example, the UK Health Security Agency reported 167 cases of listeriosis in England and Wales in 2022. The rising incidence of such diseases is propelling the demand for gastrointestinal pathogen testing.
How Is The Gastrointestinal Pathogen Testing Market segmented?
The gastrointestinal pathogen testing market covered in this report is segmented –
1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users
Subsegments:
1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens
2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens
3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens
Pre-Book The Gastrointestinal Pathogen Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Gastrointestinal Pathogen Testing Market?
Players in the gastrointestinal pathogen testing market are focusing on advanced diagnostic tools like metagenomic tests for more accurate and comprehensive pathogen detection. For example, in April 2024, Microba Life Sciences introduced MetaPanel, a metagenomic test that detects 175 gastrointestinal pathogens using next-generation sequencing technology, providing a more comprehensive diagnostic solution for healthcare professionals.
Who Are the Key Players In The Gastrointestinal Pathogen Testing Market?
Major companies operating in the gastrointestinal pathogen testing market are:
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Becton Dickinson and Company
• Hologic Inc.
• bioMérieux S.A.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• DiaSorin S.p.A.
• Cepheid Inc.
• OraSure Technologies Inc.
• BioFire Diagnostics Inc.
• Luminex Corporation
• Meridian Bioscience Inc.
• Sekisui Diagnostics LLC
• ELITechGroup S.A.S.
• Hardy Diagnostics LLC
• Trinity Biotech plc
• Puritan Medical Products Co. LLC
• Cosmo Bio Co. Ltd.
• R-Biopharm AG
• COPAN Diagnostics Inc.
• Savyon Diagnostics Ltd.
• ZeptoMetrix Corporation
• Biomerica Inc.
• Pro-Lab Diagnostics
What Is The Most Dominant Region In The Gastrointestinal Pathogen Testing Market?
North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
